Viewing Study NCT06860594


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2025-12-25 @ 11:56 PM
Study NCT ID: NCT06860594
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-07-30
Start Date Type: ACTUAL
Primary Completion Date: 2027-06-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2025-03-05
First Submit QC Date: None
Study First Post Date: 2025-03-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-23
Last Update Post Date: 2025-12-24
Last Update Post Date Type: ACTUAL